BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19317058)

  • 1. [Efficacy and safety of low-energy QS Nd:YAG and QS alexandrite laser for melasma].
    Wang HW; Liu KY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):45-7. PubMed ID: 19317058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-pulsed alexandrite and Nd:YAG lasers, individually and in combination, for leg hair reduction: an assessor-blinded, randomized trial with 18 months of follow-up.
    Davoudi SM; Behnia F; Gorouhi F; Keshavarz S; Nassiri Kashani M; Rashighi Firoozabadi M; Firooz A
    Arch Dermatol; 2008 Oct; 144(10):1323-7. PubMed ID: 18936396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy.
    Cho SB; Kim JS; Kim MJ
    Clin Exp Dermatol; 2009 Dec; 34(8):e847-50. PubMed ID: 19817757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy.
    Kim MJ; Kim JS; Cho SB
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):960-2. PubMed ID: 19207672
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
    Brown AS; Hussain M; Goldberg DJ
    J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of long-pulse alexandrite and long-pulse Nd:YAG laser systems used individually and in combination for axillary hair removal.
    Khoury JG; Saluja R; Goldman MP
    Dermatol Surg; 2008 May; 34(5):665-70; discussion 670-1. PubMed ID: 18261098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma.
    Zhou X; Gold MH; Lu Z; Li Y
    Dermatol Surg; 2011 Jul; 37(7):962-70. PubMed ID: 21615824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians.
    Lee MC; Lin YF; Hu S; Huang YL; Chang SL; Cheng CY; Chang CS
    Lasers Med Sci; 2018 Nov; 33(8):1733-1738. PubMed ID: 29732522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
    Gokalp H; Akkaya AD; Oram Y
    J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma.
    Choi M; Choi JW; Lee SY; Choi SY; Park HJ; Park KC; Youn SW; Huh CH
    J Dermatolog Treat; 2010 Jul; 21(4):224-8. PubMed ID: 20509814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: a prospective study.
    Polnikorn N
    J Cosmet Laser Ther; 2010 Jun; 12(3):126-31. PubMed ID: 20482238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riehl melanosis treated successfully with Q-switch Nd:YAG laser.
    Smucker JE; Kirby JS
    J Drugs Dermatol; 2014 Mar; 13(3):356-8. PubMed ID: 24595582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma.
    Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST
    J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients.
    Jang WS; Lee CK; Kim BJ; Kim MN
    Dermatol Surg; 2011 Aug; 37(8):1133-40. PubMed ID: 21585597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment.
    Park GH; Lee JH; Choi JR; Chang SE
    J Dermatolog Treat; 2013 Aug; 24(4):297-9. PubMed ID: 22136311
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports.
    Polnikorn N
    J Cosmet Laser Ther; 2008 Sep; 10(3):167-73. PubMed ID: 18788035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insight in the treatment of refractory melasma: Laser Q-switched Nd: YAG non-ablative fractionated followed by intense pulsed light.
    Cunha PR; Pinto CA; Mattos CB; Cabrini DP; Tolosa JL
    Dermatol Ther; 2015; 28(5):296-9. PubMed ID: 26032175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Q-switched and quasi long-pulsed 1064-nm Nd:YAG laser, non-ablative 1450-nm diode laser, and ablative 10 600-nm carbon dioxide fractional laser for enlarged pores.
    Cho SB; Noh S; Lee SJ; Kang JM; Kim YK; Lee JH
    J Dermatolog Treat; 2010 Jul; 21(4):258-60. PubMed ID: 20509817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.